DR REDDYS LABORATORIES
Back to Balance Sheet
|
DR REDDYS LABORATORIES Last 5 Year Long Term Provisions History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Long Term Provisions | ₹30 Cr | ₹24 Cr | ₹20 Cr | ₹26 Cr | ₹51 Cr |
What is the latest Long Term Provisions ratio of DR REDDYS LABORATORIES ?
| Year | Long Term Provisions |
|---|---|
| Mar2025 | ₹30 Cr |
| Mar2024 | ₹24 Cr |
| Mar2023 | ₹20 Cr |
| Mar2022 | ₹26 Cr |
| Mar2021 | ₹51 Cr |
How is Long Term Provisions of DR REDDYS LABORATORIES Trending?
| Years | Long Term Provisions | % Change | |
|---|---|---|---|
| Mar2025 | ₹30 Cr | 24.69 | |
| Mar2024 | ₹24 Cr | 20.10 | |
| Mar2023 | ₹20 Cr | -22.87 | |
| Mar2022 | ₹26 Cr | -49.21 | |
| Mar2021 | ₹51 Cr | - | |
Compare Long Term Provisions of peers of DR REDDYS LABORATORIES
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| DR REDDYS LABORATORIES | ₹98,712.3 Cr | -4.6% | -7% | 1.8% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹386,341.0 Cr | -1.8% | -6.4% | -10.7% | Stock Analytics | |
| DIVIS LABORATORIES | ₹160,401.0 Cr | -0.3% | -5.5% | 8.6% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹135,175.0 Cr | -0.1% | 4% | 18.7% | Stock Analytics | |
| CIPLA | ₹107,100.0 Cr | 1% | -12.3% | -5.2% | Stock Analytics | |
| MANKIND PHARMA | ₹86,402.2 Cr | -0.1% | -4.7% | -13.6% | Stock Analytics | |
DR REDDYS LABORATORIES Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| DR REDDYS LABORATORIES | -4.6% |
-7% |
1.8% |
| SENSEX | -1% |
-4.7% |
6% |
You may also like the below Video Courses